Pharma in Brief

DECEMBER 3, 2023

This year marks the 30-year anniversary of the Patented Medicines (Notice of Compliance) Regulations ( Regulations ), introduced in 1993 to prevent patent infringement by linking the regulatory approval of generic or biosimilar drugs with the patent rights of innovators.

Regulation 52

Regulation Compliance Medicine Manufacturing 52

Pharma in Brief

SEPTEMBER 19, 2023

Background All three decisions arose during proceedings commenced pursuant to subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations (the Regulations ). The Court concluded that there was no basis for such an Order in the Rules , the Regulations , or the jurisprudence.

Regulation 52

Regulation Generic Pharmaceutical Compliance Medicine 52

The Pharma Data

MARCH 15, 2022

The FDA regularly takes steps to help guide industry through the development process for generic drug products, including combination products, such as MDIs, that consist of a drug and a device. Source link: [link] ov/.

FDA Approval 52

FDA Approval Generic Drugs Production Drugs 52

The Pharma Data

MAY 8, 2021

Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our ambition is to be the world’s leading and most valued generics company. About Sandoz. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical needs.

Clinical Development 52

Clinical Development Medicine Development Containment 52

The Pharma Data

MAY 18, 2021

Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our ambition is to be the world’s leading and most valued generics company. About Sandoz. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical needs.

Manufacturing 40

Manufacturing Production Containment Generic Pharmaceutical 40

The Pharma Data

MAY 2, 2021

Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our ambition is to be the world’s leading and most valued generics company. About Sandoz. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical needs.

Clinical Development 40

Clinical Development Medicine Development Production 40

The Pharma Data

MAY 15, 2023

Find out more at [link] About Sandoz Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our ambition is to be the world’s leading and most valued generics company.

Sales 40

Sales Production Doctors Doctor 40